Some people choose to resume GLP-1 therapy after pregnancy and breastfeeding, while others prefer alternative weight management strategies during this life stage
Biological and molecular profile of fracture non-union tissue: current insights
Tables 2, 3, 4 and 5 summarize the main preclinical and clinical studies on the effects of DPP-4 inhibitors on bone metabolism
Ongoing phase 3 programs (such as the TRIUMPH and TRANSCEND series) continue to evaluate these outcomes in larger, longer-term settings, including direct comparisons with tirzepatide
Medicare/Medicaid policy insights and healthcare economics
Among participants with prediabetes at baseline, 87.7% achieved normoglycemia, highlighting the potential of this combination therapy to modify the natural history of dysglycemia